<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04254185</url>
  </required_header>
  <id_info>
    <org_study_id>HUM00133613</org_study_id>
    <secondary_id>U01AR073485</secondary_id>
    <nct_id>NCT04254185</nct_id>
  </id_info>
  <brief_title>Clinical Trial for Surgery of the Ulnar Nerve (SUN) at the Elbow</brief_title>
  <official_title>Clinical Trial for Surgery of the Ulnar Nerve (SUN) at the Elbow</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Curtis National Hand Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Emory Healthcare</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Norton Healthcare</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ohio State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>OrthoCarolina Research Institute, Inc.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Pittsburgh Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wake Forest University Health Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Oklahoma</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research is studying two surgical procedures in a large group of people to learn about
      how well these procedures work as a treatment for ulnar neuropathy at the elbow (UNE).
      Researchers want to see which surgery is more helpful for people with ulnar neuropathy. This
      research will determine if one surgery is better than the other to alleviate symptoms.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 18, 2020</start_date>
  <completion_date type="Anticipated">February 2025</completion_date>
  <primary_completion_date type="Anticipated">February 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>This study is a double-blind, multicenter, phase 3, randomized controlled superiority trial examining the treatment effectiveness of in-situ decompression and subcutaneous anterior transposition for UNE.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>double-blinded</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Effectiveness of surgery as measured by the Michigan Hand Outcomes Questionnaire (MHQ) summary score</measure>
    <time_frame>1 year</time_frame>
    <description>The MHQ is a self-report measure that assesses the function of the hand(s) and/or wrist(s). The MHQ contains six distinct scales assessing overall hand function, activities of daily living, pain, work performance, aesthetics and subject satisfaction with hand function. Scores range from 0-100, 100=no disability). In the pain scale, however, high scores indicate greater pain (0-100, 0=no pain).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Recovery as measured by the Michigan Hand Outcomes Questionnaire (MHQ) pain score</measure>
    <time_frame>Up to 1 year</time_frame>
    <description>The MHQ is a self-report measure that assesses the function of hand(s) and/or wrist(s). The MHQ contains six distinct scales. The score will be measured at various time points to identify the recovery trend.In a pain scale, high scores indicate greater pain (0-100, 0=no pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recovery as assessed by the Carpal tunnel questionnaire (CTQ) symptom score</measure>
    <time_frame>Up to 1 year</time_frame>
    <description>The CTQ (also known as the Levine Questionnaire, Boston Questionnaire, and the Brigham and Women's Questionnaire) contains 19 questions (11 symptom severity questions and 8 functional status questions). All questions use a scale of 1 to 5, with 1 being the best score or no symptoms.
The score will be measured at various time points to identify the recovery trend.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recovery as assessed by the Carpal tunnel questionnaire (CTQ) pain score</measure>
    <time_frame>Up to 1 year</time_frame>
    <description>The CTQ (also known as the Levine Questionnaire, Boston Questionnaire, and the Brigham and Women's Questionnaire) contains 19 questions (11 symptom severity questions and 8 functional status questions). All questions use a scale of 1 to 5, with 1 being the best score or no symptoms.
The score will be measured at various time points to identify the recovery trend.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in Grip Strength (unaffected hand - affected hand) measured by a Jamar dynamometer</measure>
    <time_frame>Up to 1 year</time_frame>
    <description>Measured in kilograms. Grip strength will be measured at various time points to identify the recovery trend.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in Pinch Strength (unaffected hand - affected hand) as measured by a pinch gauge</measure>
    <time_frame>Up to 1 year</time_frame>
    <description>Pinch strength will be recorded, to the nearest half-kilogram. It will be measured at various time points to identify the recovery trend.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in distance assessed by the 2 Point Discrimination (unaffected hand - affected hand)</measure>
    <time_frame>Up to 1 year</time_frame>
    <description>Thresholds on the tip of the finger of both hands are assessed using the method of constant stimuli. One single needle and seven pairs of needles with different spacing's are tested in randomized order. After each presentation, the subject has to report the sensation of one or two needles by answering immediately &quot;one&quot; or &quot;two.&quot; The threshold difference will be measured at various time points to identify the recovery trend.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensory difference as assessed by Semmes-Weinstein Monofilament test (unaffected hand - affected hand)</measure>
    <time_frame>Up to 1 year</time_frame>
    <description>A quantitative method to systematically assess the threshold stimulus necessary for perception of light touch to deep pressure by using monofilaments of different sizes.
Interpretation scale for monofilaments:
2.83 Normal 3.61 Diminished light touch 4.31 Diminished protective sensation 4.56 Loss of protective sensation 6.65 Deep pressure sensation only Sensory thresholds will be measured at various time points to identify the recovery trend.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complication rates for both surgical procedures assessed using a checklist</measure>
    <time_frame>Up to 1 year</time_frame>
    <description>Complications will be categorized by type, severity, and frequency captured at Surgery, 2-Week, 6-Week, 3-Month, and 12 Month Visits.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease severity as measured by ulnar neuropathy at the elbow (UNE) severity scale</measure>
    <time_frame>Enrollment, approximately day 0</time_frame>
    <description>Severity is determined based on responses to three parts sensory, motor, and test outcomes. Each part is scored 1-3, where 3=most disability.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">378</enrollment>
  <condition>Neuropathy Ulnar</condition>
  <arm_group>
    <arm_group_label>Simple decompression</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In-situ decompression releases only the compressive ligamentous structures overlying the ulnar nerve.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Subcutaneous anterior transposition</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Anterior transposition repositions the ulnar nerve, providing decompression and lengthening by moving the nerve anterior to the axis of elbow rotation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Simple decompression</intervention_name>
    <description>Surgical technique</description>
    <arm_group_label>Simple decompression</arm_group_label>
    <other_name>In-situ Decompression</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Subcutaneous anterior transposition</intervention_name>
    <description>Surgical technique</description>
    <arm_group_label>Subcutaneous anterior transposition</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  A clinical diagnosis or suspected diagnosis of isolated ulnar neuropathy at the elbow

          -  Confirmation of ulnar neuropathy using the American Association of Electrodiagnostic
             Medicine criteria for electrodiagnostic studies at the elbow. (Participants must meet
             at least 1 of the criteria to be enrolled (absolute motor nerve conduction from above
             elbow (AE) to below elbow (BE) of less than 50 m/s; An AE to BE segment greater than
             10 m/s slower than BE to wrist segment; A decrease in compound muscle action potential
             (CMAP) negative peak amplitude from BE to AE greater than 20%)

          -  Stated willingness to comply with all study procedures and availability for the
             duration of the study

          -  Able to read, understand and complete the questionnaires in English

        Exclusion Criteria:

          -  Previous elbow fracture requiring surgical fixation

          -  Patients who have not attempted conservative management for UNE (e.g. night splinting)

          -  Subluxation of ulnar nerve on preoperative exam

          -  Recurrent UNE after previous surgery

          -  Concomitant neuropathic conditions such as Carpal Tunnel Syndrome or cervical or
             brachial plexus abnormalities

          -  Participants with severe comorbid conditions that prohibit surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kevin Chung, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sunitha Malay</last_name>
    <phone>734-763-1834</phone>
    <email>smalay@umich.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Emory Healthcare</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30329</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Wagner, MD</last_name>
      <phone>404-778-3350</phone>
      <email>eric.r.wagner@emory.edu</email>
    </contact>
    <investigator>
      <last_name>Eric Wagner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Norton Healthcare</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40241</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ethan Blackburn, MD</last_name>
      <phone>502-629-4263</phone>
      <email>ethan.blackburn@nortonhealthcare.org</email>
    </contact>
    <investigator>
      <last_name>Ethan W Blackburn, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins University</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dawn LaPorte, MD</last_name>
      <phone>410-955-3134</phone>
      <email>dlaport1@jhmi.edu</email>
    </contact>
    <investigator>
      <last_name>Dawn LaPorte, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Curtis National Hand Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21218</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aviram Giladi, MD, MS</last_name>
      <phone>410-235-5405</phone>
      <email>giladi@curtishand.com</email>
    </contact>
    <investigator>
      <last_name>Aviram Giladi, MD, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Michigan Medicine</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sunitha Malay</last_name>
      <phone>734-763-1834</phone>
      <email>smalay@umich.edu</email>
    </contact>
    <investigator>
      <last_name>Kevin Chung, MD, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>OrthoCarolina Research Institute, Inc.</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>R. Glenn Gaston, MD</last_name>
      <phone>704-323-3522</phone>
      <email>Glenn.Gaston@orthocarolina.com</email>
    </contact>
    <investigator>
      <last_name>R. Glenn Gaston, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wake Forest University Health Sciences</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zhongyu Li</last_name>
      <phone>336-716-9351</phone>
      <email>zli@wakehealth.edu</email>
    </contact>
    <investigator>
      <last_name>Zhongyu Li, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sonu A. Jain, MD</last_name>
      <phone>614-366-4263</phone>
      <email>sonu.jain@osumc.edu</email>
    </contact>
    <investigator>
      <last_name>Sonu A Jain, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Oklahoma</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73126</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thomas Lehman, MD</last_name>
      <phone>405-271-4426</phone>
      <email>thomas-lehman@ouhsc.edu</email>
    </contact>
    <investigator>
      <last_name>Thomas Lehman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John R. Fowler, MD</last_name>
      <phone>412-605-3245</phone>
      <email>fowlerjr@upmc.edu</email>
    </contact>
    <investigator>
      <last_name>John R. Fowler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>January 31, 2020</study_first_submitted>
  <study_first_submitted_qc>January 31, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 5, 2020</study_first_posted>
  <last_update_submitted>July 21, 2020</last_update_submitted>
  <last_update_submitted_qc>July 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Dr. Kevin C. Chung</investigator_full_name>
    <investigator_title>Charles B de Nancrede Professor of Surgery, Professor of Surgery, Professor of Orthopaedic Surgery and Assistant Dean for Instructional Faculty, Medical School</investigator_title>
  </responsible_party>
  <keyword>Decompression</keyword>
  <keyword>Anterior Subcutaneous Transposition</keyword>
  <keyword>Elbow</keyword>
  <keyword>Ulnar Nerve</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulnar Neuropathies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

